Intellia Therapeutics NTLA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $15.05M-34.6% | $23.02M+67.0% | $13.78M-3.3% | $14.25M-14.3% | $16.63M+29.2% | ||
| $80.74M-8.9% | $88.65M-6.4% | $94.75M-2.4% | $97.04M-10.5% | $108.43M-7.2% | ||
| $34.84M+5.3% | $33.08M+8.4% | $30.51M+12.2% | $27.21M-6.2% | $29.01M-10.6% | ||
| $115.58M-5.0% | $121.73M-2.8% | $125.26M+0.8% | $124.24M-9.6% | $137.43M-8.0% | ||
| -$100.53M-1.8% | -$98.71M+11.5% | -$111.48M-1.3% | -$110M+8.9% | -$120.81M+11.5% | ||
| -668.1%-239pp | -428.9%+380pp | -808.9%-36.7pp | -772.2%-45.6pp | -726.6%+333pp | ||
| $5.21M-19.6% | $6.48M-3.5% | $6.71M-9.3% | $7.4M-14.0% | $8.6M-19.1% | ||
| $4.3M+47.1% | $2.92M-71.2% | $10.15M+16.2% | $8.74M+34.9% | $6.48M-14.2% | ||
| -$904K+65.9% | -$2.65M-177% | $3.44M+157% | $1.34M+163% | -$2.13M+31.1% | ||
| -$96.23M-0.5% | -$95.79M+5.5% | -$101.32M-0.1% | -$101.26M+11.4% | -$114.33M+11.3% | ||
| -639.5%-223pp | -416.2%+319pp | -735.2%-24.4pp | -710.8%-23.2pp | -687.6%+314pp | ||
| -$0.81+1.2% | -$0.82+10.9% | -$0.92+6.1% | -$0.98+10.9% | -$1.10+12.7% | ||
| -$0.81+1.2% | -$0.82+10.9% | -$0.92+6.1% | -$0.98+10.9% | -$1.10+12.7% | ||
| 118.5M+9.3% | 108.4M-1.6% | 110.2M+6.2% | 103.7M+0.2% | 103.5M+4.7% | ||
| 118.5M+9.3% | 108.4M-1.6% | 110.2M+6.2% | 103.7M+0.2% | 103.5M+4.7% | ||
| -$97.5M-1.8% | -$95.74M+5.2% | -$100.99M+0.7% | -$101.66M+10.7% | -$113.88M+13.5% | ||
| —— | -$0— | -$0— | -$0— | -$0— | ||
| $4.3M+47.1% | $2.92M-71.2% | $10.15M+16.2% | $8.74M+34.9% | $6.48M-14.2% | ||
| $15.05M-34.6% | $23.02M+67.0% | $13.78M-3.3% | $14.25M-14.3% | $16.63M+29.2% | ||
| -$100.53M-1.8% | -$98.71M+11.5% | -$111.48M-1.3% | -$110M+8.9% | -$120.81M+11.5% | ||
| -$98.33M-2.1% | -$96.33M+11.7% | -$109.08M-1.5% | -$107.5M+9.1% | -$118.31M+11.6% | ||
| -$98.33M-2.1% | -$96.33M+11.7% | -$109.08M-1.5% | -$107.5M+9.1% | -$118.31M+11.6% | ||
| -653.4%-235pp | -418.5%+373pp | -791.4%-36.8pp | -754.6%-43.1pp | -711.5%+328pp | ||
| -$100.53M-1.8% | -$98.71M+11.5% | -$111.48M-1.3% | -$110M+8.9% | -$120.81M+11.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Intellia Therapeutics's income statement data come from?
- Every line is extracted from Intellia Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.